Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DoubleTree Bethesdan

Sep 23, 2019 7:00 AM - Sep 24, 2019 5:00 PM

8120 Wisconsin Avenue, , Bethesda, MD 20814 , USA

Biosimilars Conference

Session 2: The Pitfalls and Promises of Real World Evidence in Evolving the Biosimilar Industry

Learning Objective : At the conclusion of this session, participants should be able to:
  • Evaluate current best-practices and challenges in RWE collection, analysis, and promotion
  • Assess evolving strategies for employing RWE in education
  • Discuss the impact RWE can have on pre-approval clinical data and the treatment pathway


Jaclyn  Bosco, PhD, MPH, FISPE


Jaclyn Bosco, PhD, MPH, FISPE

IQVIA, United States

Vice President and Global Head of Epidemiology

Nancy  Lin, DrSc, MS


Nancy Lin, DrSc, MS

Optum, United States

Senior Scientist, Epidemiology

Edward  Li, PharmD, MPH


Edward Li, PharmD, MPH

Sandoz, United States

Associate Director, HEOR & RWE

Gianluca  Trifiro, MD, PhD


Gianluca Trifiro, MD, PhD

University of Verona, Italy

Scientific Lead, INSPIRE; Professor, Pharmacology, Diagnostics and Public Health

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.